Maximo F. Nougues is CFO at PUMA BIOTECHNOLOGY, INC. (PBYI). They have made 26 open-market trades across 1 company since 2021, most recently 2026-07-06.
CIK 0001758507
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 26 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PBYI | 230,637 | $2.5M |
Shares reported on the most recent Form 4, priced at the 2026-07-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PBYI | SELL · 10b5-1 | 2026-07-06 | 2026-07-08 | $8.26 | $78K | +2.5% | +10.2% | +17.3% |
| PBYI | SELL · 10b5-1 | 2026-01-06 | 2026-01-08 | $5.86 | $64K | +13.0% | +12.8% | +23.3% |
| PBYI | SELL · 10b5-1 | 2025-07-08 | 2025-07-10 | $3.53 | $34K | -1.1% | +38.2% | +49.0% |
| PBYI | SELL · 10b5-1 | 2025-01-02 | 2025-01-03 | $3.15 | $32K | -5.9% | -13.1% | -9.0% |
| PBYI | SELL · 10b5-1 | 2024-07-17 | 2024-07-18 | $3.70 | $15K | -2.2% | -23.5% | -22.2% |
| PBYI | SELL · 10b5-1 | 2024-07-02 | 2024-07-02 | $3.27 | $17K | +18.8% | +13.6% | -17.2% |
| PBYI | SELL · 10b5-1 | 2024-01-03 | 2024-01-05 | $4.49 | $141K | +7.3% | +2.3% | +15.5% |
| PBYI | SELL · 10b5-1 | 2023-07-03 | 2023-07-06 | $3.31 | $49K | +7.8% | +28.3% | -19.9% |
| PBYI | SELL | 2023-01-03 | 2023-01-05 | $4.18 | $44K | -5.2% | -2.8% | -40.6% |
| PBYI | SELL | 2022-12-02 | 2022-12-06 | $4.50 | $716 | +15.3% | +8.2% | -29.2% |
| PBYI | SELL | 2022-11-02 | 2022-11-04 | $2.25 | $367 | +12.5% | +54.5% | +56.6% |
| PBYI | SELL | 2022-10-03 | 2022-10-05 | $2.34 | $386 | -7.4% | +11.1% | +69.3% |
| PBYI | SELL | 2022-09-02 | 2022-09-07 | $2.59 | $425 | -5.2% | -4.4% | +74.2% |
| PBYI | SELL | 2022-08-02 | 2022-08-04 | $2.89 | $465 | -3.8% | -27.4% | -36.5% |
| PBYI | SELL | 2022-07-05 | 2022-08-04 | $2.63 | $25K | -3.8% | -27.4% | -36.5% |
| PBYI | SELL | 2022-07-05 | 2022-07-07 | $2.63 | $15K | +17.9% | +24.6% | -12.9% |
| PBYI | SELL | 2022-06-02 | 2022-06-06 | $1.92 | $311 | +10.5% | +16.3% | +3.3% |
| PBYI | SELL | 2022-05-03 | 2022-05-04 | $2.34 | $386 | -22.0% | -2.9% | +22.4% |
| PBYI | SELL | 2022-04-04 | 2022-04-05 | $3.08 | $634 | -13.8% | -31.1% | -18.2% |
| PBYI | SELL | 2022-03-02 | 2022-03-04 | $2.26 | $382 | +19.3% | +27.7% | -20.5% |
| PBYI | SELL | 2022-02-02 | 2022-02-03 | $2.48 | $494 | -1.7% | +3.4% | +4.7% |
| PBYI | SELL | 2022-01-03 | 2022-01-05 | $3.19 | $24K | -14.3% | -17.7% | +12.2% |
| PBYI | SELL | 2021-12-02 | 2021-12-06 | $2.95 | $478 | +6.6% | -3.7% | -19.3% |
| PBYI | SELL | 2021-11-02 | 2021-11-03 | $5.67 | $885 | -43.8% | -54.4% | -60.2% |
| PBYI | SELL | 2021-10-04 | 2021-10-06 | $6.20 | $998 | -7.6% | -37.4% | -52.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.